Clinical Trials Logo

Clinical Trial Summary

This study was aimed to observe the efficacy of Valsalva maneuver in reducing pain intensity during spinal needle insertion.


Clinical Trial Description

Spinal anesthesia is one of the regional anesthesia techniques needed to provide motor, sensory, and autonomic blocks specifically for lower limbs by delivering local anesthetics into subarachnoid space. This technique is not difficult to perform and relatively inexpensive. However, spinal anesthesia may cause an intense pain during needle insertion. Valsalva maneuver is an attempt to force expiration by pushing a closed airway, such as covering nose or mouth. This maneuver can lead to anti-nociceptive stimulation and may decrease the pain. Thus, this study was aimed to observe the efficacy of Valsalva maneuver in reducing pain intensity during spinal needle insertion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04029662
Study type Interventional
Source Indonesia University
Contact
Status Completed
Phase N/A
Start date August 1, 2019
Completion date December 1, 2019

See also
  Status Clinical Trial Phase
Recruiting NCT03937583 - Screening for Cancer in Patients With Unprovoked VTE Phase 4
Recruiting NCT05158985 - Comparative Study Between Different Duty Cycles of Ultrasound Diclofenac Phonophoresis N/A
Recruiting NCT06336876 - Perceived Coping, Meaning, and Joy at Work N/A
Completed NCT04349761 - Single Ascending-dose Study to Evaluate Safety, Tolerability, and PK of MYMD1 in Healthy Male Adult Subjects Phase 1
Recruiting NCT04905095 - CSAPG Early Warning Score N/A
Completed NCT04438356 - M-Health Care for Patients After AMI on Disease Perception, Self-Efficacy, Anxiety and Cardio-Respiratory Fitness N/A
Recruiting NCT06216912 - Gastric Volume in Paralyzed Obese Patients After High-flow Nasal Oxygen Therapy
Recruiting NCT05675930 - A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant Phase 2
Terminated NCT04659122 - A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia Phase 1